Private Advisor Group’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-4,434
Closed -$263K 2803
2026
Q1
$263K Buy
+4,434
New +$288K ﹤0.01% 2285
2025
Q3
Sell
-3,037
Closed -$243K 2666
2025
Q2
$243K Buy
3,037
+278
+10% +$23.3K ﹤0.01% 2106
2025
Q1
$237K Sell
2,759
-557
-17% -$45.7K ﹤0.01% 2007
2024
Q4
$259K Sell
3,316
-64
-2% -$4.97K ﹤0.01% 1944
2024
Q3
$244K Buy
3,380
+457
+16% +$32.4K ﹤0.01% 2083
2024
Q2
$201K Buy
+2,923
New +$198K ﹤0.01% 2147
2020
Q3
Sell
-89
Closed -$3K 2877
2020
Q2
$3K Buy
+89
New +$3.56K ﹤0.01% 3467

Other funds holding PBH

Private Advisor Group's PBH Position: Q2 2026 in Review

Private Advisor Group sold out of Prestige Consumer Healthcare (PBH) in Q2 2026, closing a stake of 4,434 shares — an estimated $263K sold.

Private Advisor Group first reported a position in PBH in Q2 2020 and held it in 7 quarters. The position peaked at $263K in Q1 2026. 320 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Private Advisor Group reported no remaining Prestige Consumer Healthcare position as of Q2 2026 after selling out during the quarter.
  • Private Advisor Group sold 4,434 Prestige Consumer Healthcare shares in Q2 2026, an estimated $263K.
  • Private Advisor Group first reported a position in Prestige Consumer Healthcare in Q2 2020 and held it in 7 quarters.
  • Private Advisor Group's Prestige Consumer Healthcare position peaked at $263K in Q1 2026.
  • 320 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.